Antiepileptik İlaçların Çocuklar Üzerindeki İstenmeyen Etkileri
Özet
Bu bilimsel metin, çocukluk çağında en sık karşılaşılan nörolojik rahatsızlıklardan biri olan epilepsinin tedavisinde ilk seçenek olarak kabul edilen antiepileptik ilaçların (AEİ) çocuklar üzerindeki istenmeyen etkilerini ve bu süreçte pediatri hemşirelerinin üstlendiği kritik rolleri ele almaktadır. Küresel ölçekte epilepsi hastalarının %20'sini çocukların oluşturduğu ve bu ilaçları kullanan her üç çocuktan birinde çeşitli yan etkilerin ortaya çıktığı bildirilmektedir. AEİ kullanımı; motor hareket, davranış, duygu durum, uyku, gastrointestinal ve hepatobiliyer sistem bozuklukları gibi çocuk ile ailesinin yaşam kalitesini doğrudan düşüren birçok probleme sebebiyet vermektedir. Örneğin, iki yaş altındaki çocuklarda valproat kullanımı ölümcül hepatotoksisite ve Stevens-Johnson sendromu riskini artırırken, 12 yaş üzerindeki çocuklarda felbamat kullanımı aplastik anemiye yol açabilmektedir. Ayrıca fenitoin ve fenobarbital gibi ilaçlar karaciğer enzimlerini indükleyip D vitamini ve kalsiyum emilimini bozarak çocuklarda raşitizme ve büyüme geriliğine neden olmaktadır. İlaçların iyon kanallarını etkileyerek QT aralığını uzatması kardiyak aritmi riskini doğururken, birden fazla ilaç içeren politerapi uygulamaları yan etkilerin görülme sıklığını daha da artırmaktadır. Sağlık ekibinin vazgeçilmez bir parçası olan pediatri hemşireleri ise ailelere kapsamlı epilepsi eğitimi sunmak, ilaç dozları ve yan etkiler hakkında danışmanlık yapmak, ilaç saatlerini günlük yaşam tarzına göre planlamak ve advers reaksiyonların erken teşhisi için farmakovijilans takibini titizlikle yürütmekle görevlidir.
This scientific text addresses the undesirable effects on children of antiepileptic drugs (AEDs), which are considered the first choice in the treatment of epilepsy—one of the most common neurological disorders in childhood—and the critical roles assumed by pediatric nurses in this process. It is reported that children constitute 20% of epilepsy patients globally, and various side effects occur in one out of every three children using these drugs. The use of AEDs causes many problems that directly reduce the quality of life of both the child and their family, such as motor movement, behavioral, mood, sleep, gastrointestinal, and hepatobiliary system disorders. For instance, while valproate use in children under two years of age increases the risk of fatal hepatotoxicity and Stevens-Johnson syndrome, felbamate use in children over 12 years of age can lead to aplastic anemia. Additionally, drugs such as phenytoin and phenobarbital induce liver enzymes and impair the absorption of vitamin D and calcium, causing rickets and growth retardation in children. The elongation of the QT interval due to drugs affecting ion channels creates a risk of cardiac arrhythmia, while polytherapy applications involving more than one drug further increase the incidence of side effects. As an indispensable part of the healthcare team, pediatric nurses are responsible for providing comprehensive epilepsy education to families, counseling on drug doses and side effects, planning medication schedules according to daily lifestyle, and meticulously conducting pharmacovigilance tracking for the early detection of adverse reactions.
Referanslar
Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood. Position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia, 2022; 63(6): 1398-1442. doi: /10.1111/epi.17241
Fisher RS, Boas WVE, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 2005; 46(4): 470-472. doi: 10.1111/j.0013-9580.2005.66104.x
Ali R, Connolly ID, Feroze AH, et al. Epilepsy: a disruptive force in history. World Neurosurgery, 2014; 90: 685-690. doi: 10.1016/j.wneu.2015.11.060
Yüce N, Yeni Kuşak Antiepileptik İlaçların Klinik Etkinliği ve Yan Etkileri. PhD Thesis. (2009). Bursa Uludag University (Turkey).
Khalili N, Doosti-Irani A, Moradi A, et al. Patterns of Antiepileptic Drug Reactions in Children: A Multicenter Study. Iranian Journal of Child Neurology, 2022; 16(3): 133-143. doi: 10.22037/ijcn.v16i3.32872
Machmoed HA, Bubakar NA, Urfianty IJG, et al. Correlatıon between the duratıon of antı-epıleptıc drugs therapy and vıtamın d level ın epıleptıc chıldren. International Journal of Health Science, 2022; 2(1): 3.
Syvertsen M, Koht J, Nakken KO. Prevalence and incidence of epilepsy in the Nordic countries. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 2015; 135(18): 1641-1645. doi: 10.4045/tidsskr.15.0454
Aaberg KM, Gunnes N, Bakken IJ, et al. Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics, 2017; 139(5). doi: 10.1542/peds.2016-3908
Landmark CJ, Johannessen SI, Tomson T. Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring. Epileptic disorders, 2016; 18(4): 367-383.
Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nature reviews neuroscience, 2004; 5(7): 553-564.
Dodson WE, Pharmacology and therapeutics of epilepsy in childhood. Clinical neuropharmacology, 1979; 4: 1-30.
Golden AS, Haut SR, Moshé SL. Nonepileptic uses of antiepileptic drugs in children and adolescents. Pediatric neurology, 2006; 34(6):421-432.doi: 10.1016/j.pediatrneurol.2005.08.017
Lee HS, Wang SY, Salter DM, et al. The impact of the use of antiepileptic drugs on the growth of children. BMC pediatrics, 2013; 13(1): 1-7.
Kothare SV, Kaleyias J. The adverse effects of antiepileptic drugs in children. Expert opinion on drug safety, 2007; 6(3): 251-265.
Dreifuss FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs. Epilepsia, 1987; 28: 23-29. doi: 10.1111/j.1528-1157.1987.tb05768.x
Brown WM, Aiken SP. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Critical Reviews™ in Neurobiology, 1998;12(3): 205-222.doi: 10.1615/CritRevNeurobiol.v12.i3.30
Baek JH, Seo YH, Kim GH, et al. Vitamin D levels in children and adolescents with antiepileptic drug treatment. Yonsei medical journal, 2014; 55(2): 417-421. doi: 10.3349/ymj.2014.55.2.417
Saket S, Varasteh N, Asl AA, et al. How antiepileptics may change the serum level of vitamin D, calcium, and phosphorus in children with epilepsy. Iranian Journal of Child Neurology, 2021; 15(1): 19-27. doi: 10.22037/ijcn.v15i1.25952
AlKataan MAA, Mahmood AS, AlMallakhdeer AS. Evaluation of the Detrimental Effects of some Antiepileptic Drugs on the Height and Weight of Children with Epilepsy. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512), 2022; 31(1): 241-245. doi: 10.31351/vol31iss1pp241-245
Jakubus T, Michalska-Jakubus M, Łukawski K, et al. Atherosclerotic risk among children taking antiepileptic drugs. Pharmacological reports, 2009; 61(3), 411-423. doi: 10.1016/S1734-1140(09)70082-9
Mahmoud AA, Aboelghar HM, Abdelmageed SM, et al. Assessment of asymmetric dimethylarginine and homocysteine in epileptic children receiving antiepileptic drugs. Pediatric Research, 2022; 1-7. doi: 10.1038/s41390-022-02132-6
Kopciuch D, Kus K, Fliciński J et al. Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs. International journal of environmental research and public health, 2022; 19(8): 4509. doi: 10.3390/ijerph19084509
Eroglu TE, Folke F, Tan HL, et al. Risk of out‐of‐hospital cardiac arrest in patients with epilepsy and users of antiepileptic drugs. British Journal of Clinical Pharmacology, 2022; 2. doi: 10.1111/bcp.15313
Kwon S, Lee S, Hyun M, et al. The potential for QT prolongation by antiepileptic drugs in children. Pediatric neurology, 2004; 30(2): 99-101. doi: 10.1016/S0887-8994(03)00405-3
Lai ECC, Yang YHK, Lin SJ, et al. Use of antiepileptic drugs and risk of hypothyroidism. Pharmacoepidemiology and drug safety, 2013; 22(10): 1071-1079. doi: 10.1002/pds.3498
Palm L, Anderson H, Elmqvist D, et al. Daytime sleep tendency before and after discontinuation of antiepileptic drugs in preadolescent children with epilepsy. Epilepsia, 1992; 33(4): 687-691. doi: 10.1111/j.1528-1157.1992.tb02348.x
Cortesi F, Giannotti F, Ottaviano S. Sleep problems and daytime behavior in childhood idiopathic epilepsy. Epilepsia, 1999; 40(11): 1557-1565. doi: 10.1111/j.1528-1157.1999.tb02040.x
Guvenir H, Misirlioglu ED, Civelek E, et al. The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study. The Journal of Allergy and Clinical Immunology: In Practice, 2018; 6(6): 2043-2050. doi: 10.1016/j.jaip.2018.02.018
Hausman SV, Luckstein RR, Zwygart AM, et al. Epilepsy education: a nursing perspective. In Mayo Clinic Proceedings, 1996; 71(11): 1114-1117. doi: 10.4065/71.11.1114
Guvenir H, Misirlioglu ED, Civelek E, et al. The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study. The Journal of Allergy and Clinical Immunology: In Practice, 2018; 6(6): 2043-2050. doi: 10.1016/j.jaip.2018.02.018
Güven ŞT, Dalgıç Aİ, Epilepsi Hastalığı Olan Çocuklarda Kullanılan Antiepileptik İlaçlar ve İlaç Yönetiminde Hemşirelik Yaklaşımının Önemi. Uluslararası Hakemli Hemşirelik Araştırmaları Dergisi, 2017; 9: 188-202.
Walker MP, McGovern TL, Hattingh LH, et al. Medication management of adult patients admitted to hospital with epilepsy, seizure or convulsion. Journal of Pharmacy Practice and Research, 2022; 42(4): 291-295. doi: 10.1002/j.2055-2335.2012.tb00191.x
Güven ŞT, İşler A. Validity and reliability of the seizure self-efficacy scale for children with epilepsy. Nöro Psikiyatri Arşivi, 2015; 52(1): 47-53. doi: 10.5152/npa.2015.7399
